AMLX

AMLX Gross Profit Growth

13.97%TTM

Period ending:

AMLX TTM Gross Profit YoY %%
AMLX TTM Gross Profit YoY %18003.21%-2115.67%
2022-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

AMLX gross profit growth history

Year-over-year gross profit growth rate. The available trailing twelve months (ttm) series contains 16 observations from Sep 30, 2022 to Jun 30, 2026.

Amylyx Pharmaceuticals Inc Gross Profit Growth — Trailing twelve months (TTM)
Period endingGross Profit Growth
13.9678%
36.5236%
-12.6848%
-168.6854%
-114.5599%
-112.1735%
-110.5447%
-77.3776%
-10.0361%
206.1969%
16,056.2191%
893.7725%
610.6948%
286.4765%
92.8592%
-94.9362%

Compare gross profit growth

All AMLX financial metrics · AMLX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.